StateFair ETF
Founder
Christalyn Rhodes
Ph.D. Harvard, Former Flagship Venture Associate, 3 VC funded biotech startups, Inventor-5 patents
Founder ARC Therapeutics- drug discovery,Co-founder FL64 (A Flagship Pioneering company), Founder State Fair- a bio-sciences fin-tech company
Ph.D. Harvard, Former Flagship Venture Associate, 3 VC funded biotech startups, Inventor-5 patents
Founder ARC Therapeutics- drug discovery,Co-founder FL64 (A Flagship Pioneering company), Founder State Fair- a bio-sciences fin-tech company
There was a problem loading your content.
Experience
Flagship Ventures
Employee
Eli Lilly
Employee
Umass Medical School
Advisor
Founder
Employee
Advisor
Education
About
Achievements
I am a pioneer of biotech impact investing and the developer of first-in-class health equity financial instruments. I started the FAIR100 Health Equity index, which facilitates investments in companies developing assets that mitigate the disparate impact of disease.
The index, launched Q1 2021, realized 187% return on investment (compared to the 31% return of the industry standard biotech index XBI during the same time) as verified by third-party analysis.
I am also an inventor holding 5 patents on platform drug development technologies.
Additionally, I have received numerous awards for innovation across diverse sectors including academia, VC and Pharma.
Describe the most impressive thing you've done.
Skills
What I'm Looking For
I am looking to fund early-stage technology companies developing disruptive technology, assets or platforms that mitigate the disparate impact of disease. We are open to investing in pre-seed to pre-IPO companies in all sectors with direct or indirect impact on health and/or quality of life including health technology, biotech, fintech, food security and AI-companies.
Describe what you're looking for in a company.
Q&A
What's the most useful business-related book you've ever read?
Range- David Epstein
What's your favorite non-business book?
Outliers- Malcolm Gladwell